Evaluation of optimal psoriasis assessment tool (OPAT) incorporating both clinical and patient-reported outcomes for treatment of moderate-to-severe plaque psoriasis

被引：0
|
作者：
Leonardi, C. [2 ]
See, K. [1 ]
Burge, R. [1 ]
Gallo, G. [1 ]
McKean-Matthews, M. [3 ]
Goldblum, O. [1 ]
Wu, J. [4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Cent Dermatol, St Louis, MO USA
[3] Syneos Hlth, Raleigh, NC USA
[4] Dermatol Res & Educ Fdn, Irvine, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
541
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [41] Development of a patient-reported outcomes instrument for the measurement of treatment satisfaction in plaque psoriasis
    Armstrong, April
    Sundaram, Murali
    Foley, Catherine
    Pompilus, Farrah
    Stokes, Jonathan
    Shields, Alan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S34 - S34
  • [42] Changes in patient-reported outcomes with etanercept treatment following apremilast failure in patients with moderate to severe psoriasis
    Bagel, Jerry
    Stolshek, Bradley S.
    Samad, Ahmed S.
    Yang, Yue
    Chung, James B.
    Kricorian, Gregory
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB180 - AB180
  • [43] IQVIA PATIENT DATA ASSESSMENT: REAL WORLD EVIDENCE IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Sousa, J.
    Valadas, F.
    VALUE IN HEALTH, 2018, 21 : S461 - S461
  • [44] Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab
    Malakouti, Mona
    Jacob, Sharon E.
    Anderson, Nancy J.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2016, 9 : 347 - 355
  • [45] Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis
    Vu, Trang T.
    Gooderham, Melinda
    Papp, Kim
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (11) : 1423 - 1433
  • [46] TREATMENT SATISFACTION AMONG PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL
    Lopes, N.
    Suarez, R. M.
    Sabbag, C. Y.
    Kobata, C. M.
    Takemoto, M. S.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [47] A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
    Yifan Hu
    Zeyu Chen
    Yu Gong
    Yuling Shi
    Clinical Drug Investigation, 2018, 38 : 191 - 199
  • [48] A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
    Hu, Yifan
    Chen, Zeyu
    Gong, Yu
    Shi, Yuling
    CLINICAL DRUG INVESTIGATION, 2018, 38 (03) : 191 - 199
  • [49] Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura K.
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
  • [50] Bimekizumab in moderate-to-severe plaque psoriasis: evaluation of clinical and molecular evidence to understand maintenance of response
    Kreuger, J.
    Oliver, R.
    Glatt, S.
    Page, M.
    Edwards, H.
    Garcet, S.
    Dizier, B.
    Maroof, A.
    Shaw, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E48 - E48
12345